Analyst Research

Report Title Price
Provider: Thomson Reuters Stock Report
Provider: New Constructs, LLC
Provider: Stock Traders Daily
Provider: ValuEngine, Inc.

NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.

Abbott Laboratories' Subsidiary Announces Pricing Of $14.7 Billion Private Placement Notes Offering

Monday, 5 Nov 2012 06:56pm EST 

Abbott Laboratories announced that wholly owned subsidiary, AbbVie Inc., priced the private placement offering launched on November 5, 2012, of $3.5 billion of 1.20% senior notes due 2015, $4 billion of 1.75% senior notes due 2017, $1 billion of 2.00% senior notes due 2018, $3.1 billion of 2.90% senior notes due 2022, $2.6 billion of 4.40% senior notes due 2042, and $500 million of floating rate senior notes due 2015 (the Floating Rate Notes, and, together with the 2015 Notes, the 2017 Notes, the 2018 Notes, the 2022 Notes and the 2042 Notes, the Notes). The closing of the offering is expected to occur on November 8, 2012. Abbott intends to use the proceeds it receives from AbbVie, in part, to fund previously announced cash tender offers for certain of Abbott's outstanding notes. 

Company Quote

0.443 +1.03%
1:31pm EDT